Auriga Downgrades Omnicell (OMCL) to Hold; Tougher Competition on Continued Lackluster Hospital Spending
Tweet Send to a Friend
Auriga downgrades Omnicell (Nasdaq: OMCL) from Buy to Hold. price target lowered to $12 from $13.
Auriga analyst says, "The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Auriga analyst says, "The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
